Australia’s Cogstate (ASX:CGS) Inks USD3.2m Deal for Alzheimer’s Disease Trial Australia December 22, 2015 MELBOURNE, AUSTRALIA – Cognitive science firm Cogstate (ASX:CGS) announced that it has signed a contract with a large international pharmaceutical…
